4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-030725
EVP & Chief Strategy Officer gave up 382 shares (to pay taxes)
From the SEC's structured data for this filing
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-030725
EVP & Chief Strategy Officer gave up 382 shares (to pay taxes)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…